Literature DB >> 7535828

Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons.

S P Blatt1, W F McCarthy, B Bucko-Krasnicka, G P Melcher, R N Boswell, J Dolan, T M Freeman, J M Rusnak, R E Hensley, W W Ward.   

Abstract

Nine hundred thirty persons enrolled in the US Air Force Human Immunodeficiency Virus (HIV) Natural History Study were evaluated with a standard battery of 30 potential surrogate markers of disease progression. A risk score for predicting progression to AIDS was then calculated for each patient in the cohort by using the four highest-ranking variables from multivariate analysis: percentage of CD4 CD29 cells, anergy status, age, and hemoglobin. For predicting survival, beta 2-microglobulin replaced age in the Cox model. Stratification according to the risk score demonstrated that rates of progression to AIDS and survival were significantly different between risk groups (P < .0001). The novel combination of these markers results in extremely accurate risk scores, which may serve as the basis for the development of true surrogate markers of disease progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535828     DOI: 10.1093/infdis/171.4.837

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2.

Authors:  B R Gundlach; H Linhart; U Dittmer; S Sopper; S Reiprich; D Fuchs; B Fleckenstein; G Hunsmann; C Stahl-Hennig; K Uberla
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Delayed-type hypersensitivity and hepatitis B vaccine responses, in vivo markers of cellular and humoral immune function, and the risk of AIDS or death.

Authors:  Shane B Patterson; Michael L Landrum; Jason F Okulicz
Journal:  Vaccine       Date:  2014-04-29       Impact factor: 3.641

3.  Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines.

Authors:  B R Gundlach; S Reiprich; S Sopper; R E Means; U Dittmer; K Mätz-Rensing; C Stahl-Hennig; K Uberla
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Impaired Neurocognitive Performance and Mortality in HIV: Assessing the Prognostic Value of the HIV-Dementia Scale.

Authors:  Nikhil Banerjee; Roger C McIntosh; Gail Ironson
Journal:  AIDS Behav       Date:  2019-12

5.  Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.

Authors:  B R Gundlach; M G Lewis; S Sopper; T Schnell; J Sodroski; C Stahl-Hennig; K Uberla
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 6.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.

Authors:  Alan Landay; Lorie Benning; James Bremer; Barbara Weiser; Harold Burger; Marek Nowicki; Andrea Kovacs
Journal:  J Infect Dis       Date:  2003-07-01       Impact factor: 5.226

8.  nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes.

Authors:  Chie Sugimoto; Kei Tadakuma; Isao Otani; Takashi Moritoyo; Hirofumi Akari; Fumiko Ono; Yasuhiro Yoshikawa; Tetsutaro Sata; Shuji Izumo; Kazuyasu Mori
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Host factors determine differential disease progression after infection with nef-deleted simian immunodeficiency virus.

Authors:  Sieghart Sopper; Kerstin Mätz-Rensing; Thorsten Mühl; Jonathan Heeney; Christiane Stahl-Hennig; Ulrike Sauermann
Journal:  J Gen Virol       Date:  2014-06-13       Impact factor: 3.891

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.